Ekso Bionics will release its Q4 and full year 2024 financial results on March 3, 2025, with a conference call afterward. Ekso Bionics Holdings, Inc. announced that it will release its financial and ...
SAN RAFAEL, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced ...
SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced ...
Ekso Bionics reports record Q4-2024 revenue of $5.1 million with improved gross margins and strategic distributor partnership. Ekso Bionics Holdings, Inc., a leader in exoskeleton technology, reported ...
Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.14 EPS, expectations were $-0.07. Operator: Greetings. And welcome to the Ekso Bionics Holdings, Inc. Fourth Quarter ...
SAN RAFAEL, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and ...
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2024 Earnings Call Transcript March 3, 2025 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.14 EPS, expectations were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback